These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9034984)

  • 1. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
    Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis.
    Huskisson EC; Ghozlan R; Kurthen R; Degner FL; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():29-34. PubMed ID: 8630633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A
    Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis.
    Reginster JY; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():17-21. PubMed ID: 8630631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
    Lund B; Distel M; Bluhmki E
    Scand J Rheumatol; 1998; 27(1):32-7. PubMed ID: 9506875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of meloxicam: a global analysis of clinical trials.
    Distel M; Mueller C; Bluhmki E; Fries J
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():68-77. PubMed ID: 8630641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
    Yocum D; Fleischmann R; Dalgin P; Caldwell J; Hall D; Roszko P
    Arch Intern Med; 2000 Oct; 160(19):2947-54. PubMed ID: 11041902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
    Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
    Bevis PJ; Bird HA; Lapham G
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L; Kneer W; Baturone M; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F; Sigmund R; Zeidler H
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
    Cheng TT; Lai HM; Chiu CK; Chem YC
    Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
    Dreiser RL; Le Parc JM; Vélicitat P; Lleu PL
    Inflamm Res; 2001 Mar; 50 Suppl 1():S17-23. PubMed ID: 11339516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.